Fig. 1From: Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot studyEnrollment. Twenty participants were included in the final analysis. Two completed only 6 weeks of the study and received 2 weeks of placebo and 4 weeks of sodium bicarbonateBack to article page